Pathogenesis of Multiple Organ Dysfunction Syndrome - Endotoxin, Inflammatory Cells, and Their Mediators: Cytokines and Reactive Oxygen Species
- 1 September 2000
- journal article
- review article
- Published by Mary Ann Liebert Inc in Surgical Infections
- Vol. 1 (3) , 197-205
- https://doi.org/10.1089/109629600750018123
Abstract
Multiple organ dysfunction syndrome (MODS) is caused by an overwhelming, uncontrolled systemic inflammatory response that is activated by a number of hostile stimuli including sepsis, hypovolemic shock, and severe trauma resulting in massive tissue injury. The indiscriminate activation of the inflammatory response due to these insults causes loss of the host's ability to localize the inflammation to the focus of the problem, leading to systemic inflammation and severe host tissue damage and subsequent MODS. While the major players, namely neutrophils, macrophages, endotoxin, cytokines, and oxidants have been known for some time, the disease processes responsible for the pathogenesis of MODS have only recently been elucidated. Our newly found knowledge has resulted in the development of novel therapeutic strategies to prevent or treat MODS, such as scavenging toxic oxygen species and inhibiting endotoxin, or cytokine production, or cytokine activity. Unfortunately, these strategies have not resulted in improved mortality rates among patients with MODS. The complex nature of the host response to severe insults combined with the fact that the host has multiple, redundant parallel systems to deal with various insults has made it difficult for clinical interventions to adequately ameliorate the disease process among patients at risk for MODS. The purpose of this article is to attempt to "dissect out" several individual components of the inflammatory response that play important roles in the development of MODS and to review some potentially beneficial approaches to combat these harmful processes.Keywords
This publication has 27 references indexed in Scilit:
- The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acidPublished by Elsevier ,2003
- Deciphering the oxyradical inflammation Rosetta stoneCritical Care Medicine, 1999
- Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shockThe Lancet, 1998
- Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxiaEuropean Respiratory Journal, 1997
- INTERSEPTCritical Care Medicine, 1996
- Antibiotic-induced release of endotoxin from bacteria in vitroJournal of Medical Microbiology, 1994
- A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndromeCritical Care Medicine, 1993
- Effect of antibiotics on endotoxin release from gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 1993
- Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndromeCritical Care Medicine, 1992
- Ketoconazole Prevents Acute Respiratory Failure in Critically Ill Surgical PatientsPublished by Wolters Kluwer Health ,1988